IWP: Strong Growth Profile, Better Mid-Cap Options Elsewhere

The iShares Russell Mid-Cap Growth ETF (IWP) holds a portfolio of growth stocks in the mid-cap range. Investors who sit with it are paying for a footprint that trails comparable funds on both cost and recent performance.

IWP tracks the Russell Midcap Growth Index, which covers companies in the market-cap band between roughly $2 billion and $10 billion. The ETF spreads capital across 300-plus positions. Top holdings include CrowdStrike Holdings, Palo Alto Networks, and Dexcom. That diversification cuts single-name risk. It also dilutes the kind of concentrated bet that drives excess returns in a mid-cap growth rally.

The fund's expense ratio sits at 0.18%. That is not expensive in absolute terms – many active mid-cap funds charge north of 1%. It is roughly double the fee on the Vanguard Mid-Cap Growth ETF (VOT). Over a decade, that 9-basis-point gap compounds into a material drag. A $10,000 investment in IWP costs $18 a year. The same sum in VOT costs $9. On a $100,000 position, the difference is $90 annually. For a product that is already a passive beta play, the fee premium is hard to justify.

On valuation, the index trades at roughly 32 times trailing earnings. That is a premium to the broader mid-cap market, which is priced around 24 times. The growth premium is real – portfolio holdings like CRISPR Therapeutics and Bill Holdings carry higher revenue growth rates than the average mid-cap. The market already prices that expectation in. A growth scare or a rotation into value would hit IWP harder than cheaper mid-cap ETFs.

Trailing one-year returns through April show IWP up about 12%. VOT returned 14% over the same period. The iShares S&P Mid-Cap 400 Growth ETF (IJK) returned 16%. The gap is not huge. It is consistent across rolling three-year and five-year windows. The Russell-index construction method – which rebalances annually and uses a pure-growth classification – tends to cut positions that cross into value territory late, missing the peak of some momentum runs.

For an investor who wants mid-cap growth exposure and values the Russell brand, IWP is functional. For someone optimizing on fees, tax efficiency, or recent track record, cheaper alternatives offer the same factor with less drag. The core argument for IWP – that its breadth and index methodology deliver diversification – is sound. The premium to its cheapest peer is an expense that shows no compensating return advantage.

The practical choice for a watchlist: if the portfolio already uses Russell-index products for the small-cap or large-cap allocations, IWP may be the natural fit for consistency. For a stand-alone mid-cap growth allocation, the fee and return gap favor VOT or IJK.